Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $386.3800 (-1.42%) ($382.7800 - $393.5000) on Tue. May. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 48 | Latest Price | $386.3800(-1.42%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(51%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.48% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $377.06(2.47%) | 10 Day Moving Average | $375.81(2.81%) | 20 Day Moving Average | $384.21(0.56%) | To recent high | -9.6% | To recent low | 7.4% | Market Cap | $40.967b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |